Can infliximab efficacy be predicted based on blood concentration at the fourth dose?

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2017
This article has no abstract
Epistemonikos ID: 8e30a743f8894806eeebe0a75ab4b28ae05f3005
First added on: Mar 24, 2022